Skip to Content

CME Group Inc Class A

CME: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$751.00ClbwDzpvwrbsx

CME Earnings: High Interest-Rate Futures Volume Drives Strong Growth

Wide-moat CME Group reported strong fourth-quarter results as volatile fixed-income markets drove higher volume for the firm’s interest-rate futures. Revenue increased 19% from last year and 7.6% from last quarter to $1.44 billion. Diluted earnings per share increased 23.4% from last year to $2.37. As we incorporate these results, we do not plan to materially alter our $220 fair value estimate. We see the shares as fairly valued.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of CME so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center